EWM
Essex Woodlands Management Portfolio holdings
AUM
$279M
This Quarter Return
-1.62%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$445M
AUM Growth
+$445M
(-1.3%)
Cap. Flow
+$14.4M
Cap. Flow
% of AUM
3.25%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
2
Reduced
2
Closed
–
Top Buys
| 1 |
Venus Concept
VERO
|
$11.5M |
| 2 |
SONX
Sonendo, Inc.
SONX
|
$11.5M |
| 3 |
TELA Bio
TELA
|
$925K |
Top Sells
| 1 |
Axogen
AXGN
|
$9.18M |
| 2 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$253K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bioventus
BVS
$495M
| $175M | 39.42% | 12,096,702 | – | – |
|
2
MiMedx Group
MDXG
$1.05B
| $141M | 31.75% | 23,376,623 | – | – |
|
3
EyePoint Pharmaceuticals
EYPT
$797M
| $51.3M | 11.54% | 4,190,921 | – | – |
|
|
4
Venus Concept
VERO
$4.11M
| $27.8M | 6.25% | 21,169,457 +8,751,601 | +70% | +$11.5M |
|
|
5
TELA Bio
TELA
$70.5M
| $24.4M | 5.49% | 1,906,228 +72,239 | +4% | +$925K |
|
|
SONX
6
DELISTED
Sonendo, Inc.
SONX
| $11.5M | 2.58% | +1,992,526 | New | +$11.5M |
|
|
RVNC
7
DELISTED
Revance Therapeutics, Inc.
RVNC
| $7.46M | 1.68% | 457,085 -15,505 | -3% | -$253K |
|
8
MediciNova
MNOV
$64.3M
| $2.96M | 0.67% | 1,105,941 | – | – |
|
|
9
Axogen
AXGN
$743M
| $2.78M | 0.62% | 296,416 -980,229 | -77% | -$9.18M |
|
10
Gyre Therapeutics
GYRE
$703M
| $72K | 0.02% | 78,622 | – | – |
|